Ricerca avanzata

La signora Mardi C. Dier è direttore finanziario e vicepresidente esecutivo di Ultragenyx Pharmaceutical, Inc., direttore indipendente di Oric Pharmaceuticals, Inc. e direttore indipendente di Adamas Pharmaceuticals, Inc. Fa parte del Consiglio di amministrazione di Prelude Therapeutics, Inc., Oric Pharmaceuticals, Inc. e Adamas Pharmaceuticals, Inc. La sig.ra Dier è stata precedentemente impiegata come CFO, Chief Business Officer & Executive VP di Portola Pharmaceuticals, Inc., Vice President-Investor Relations di Chiron Corp., Director-Investment Banking di Prudential Equity Group LLC, Senior Accountant di KPMG LLP, Senior Accountant di KPMG Peat Marwick LLP e Director-Investment Banking di Prudential Securities. È stata anche membro del consiglio di amministrazione del Jewish Vocational Service, Inc. e del Futures Strategic Trust. Si è laureata alla Stanford University e ha conseguito un MBA alla UCLA Anderson School of Management.

Andreas Dier currently works as a Co-Managing Director at Alles rund ums Rohr - Arbeitnehmerüberlassung GmbH.

Louise Dier served as an Independent Non-Executive Director at TClarke Plc from 2019 to 2022.
Prior to that, she worked as a Managing Director at David Chipperfield Architects Ltd., General Manager-United Kingdom at DO & CO Catering-Consult & Beteiligungs GmbH, and Head-Human Resources at IMG Europe Ltd.
She graduated from the University of Cambridge.

Martina Dier has a current job as the Director of Global Communications at TeamViewer SE.

Gregory Dier worked as an Associate Research Analyst at Hartford Investment Management Co..
Mr. Dier attended Middlebury College, where he received an undergraduate degree in 2013.

Chris Dier worked as a Principal at Intel Corp.
and as a Chief Financial Officer at The Solaria Corp.
and OuterBay Technologies, Inc. He obtained an undergraduate degree and an MBA from Santa Clara University.

Rachid Mardi currently works as the Head-Client Accounting at Maroc Leasing SA.

Mardi Gilkey has a current job as a Secretary at Metropolitan Youth Symphony.

Mac Mardi is currently the Chief Executive Officer at Fuerst Day Lawson Ltd.
and a Director at Fuerst Day Lawson (U.S.A.) Ltd., FDL Holdings Ltd., FDL Acquisition No.
1 Ltd., and FDL Acquisition No.
2 Ltd.
He previously held the position of Chief Executive Officer at Invensys Ltd.
and RTS Ltd.
He was also the Chairman of IPBlaze A.
Additionally, he served as a Director at Fuerst Day Lawson Holdings Ltd.
from 2006 to 2020 and as the Vice President-Global Operations at DuPont Nutrition Biosciences ApS.
He was also a Principal at BI Software Ltd.

Mardi Peaster worked at Jones Lang LaSalle, Inc. from 2004 to 2019.
Her former job title was Senior Specialty Leasing & Marketing Manager, which she held from 2014 to 2019.

Mohamed Mardi bin Ismail is currently working as the Head of Risk Management, Integrity & Compliance at TDM Bhd.